Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
0.926
+0.060 (6.93%)
Mar 9, 2026, 3:41 PM EDT - Market open
Rockwell Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 75.58 | 101.49 | 83.61 | 72.81 | 61.93 | 62.2 | Upgrade
|
| Revenue Growth (YoY) | -23.60% | 21.38% | 14.84% | 17.57% | -0.43% | 1.46% | Upgrade
|
| Cost of Revenue | 64.13 | 84.01 | 74.91 | 68.73 | 64.35 | 59.47 | Upgrade
|
| Gross Profit | 11.45 | 17.48 | 8.7 | 4.08 | -2.42 | 2.73 | Upgrade
|
| Selling, General & Admin | 16.26 | 16.86 | 14.27 | 17.74 | 21.08 | 24.05 | Upgrade
|
| Research & Development | 0 | 0.02 | 1.11 | 3.12 | 6.84 | 7.09 | Upgrade
|
| Operating Expenses | 16.26 | 16.88 | 15.37 | 20.86 | 27.92 | 31.15 | Upgrade
|
| Operating Income | -4.81 | 0.61 | -6.67 | -16.78 | -30.34 | -28.42 | Upgrade
|
| Interest Expense | -1.13 | -1.25 | -2.3 | -1.94 | -2.36 | -1.88 | Upgrade
|
| Interest & Investment Income | 0.22 | 0.09 | 0.21 | 0.03 | 0.02 | 0.24 | Upgrade
|
| EBT Excluding Unusual Items | -5.72 | -0.55 | -8.76 | -18.68 | -32.67 | -30.06 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.2 | 0.07 | 0.32 | 0 | - | 0.01 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -0.84 | Upgrade
|
| Pretax Income | -5.52 | -0.48 | -8.44 | -18.68 | -32.67 | -30.89 | Upgrade
|
| Net Income | -5.52 | -0.48 | -8.44 | -18.68 | -32.67 | -30.89 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.42 | 0.3 | 0.15 | - | - | - | Upgrade
|
| Net Income to Common | -5.93 | -0.78 | -8.59 | -18.68 | -32.67 | -30.89 | Upgrade
|
| Shares Outstanding (Basic) | 34 | 31 | 23 | 14 | 9 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 31 | 23 | 14 | 9 | 7 | Upgrade
|
| Shares Change (YoY) | 14.40% | 33.17% | 63.05% | 67.77% | 24.02% | 24.14% | Upgrade
|
| EPS (Basic) | -0.17 | -0.03 | -0.37 | -1.31 | -3.83 | -4.49 | Upgrade
|
| EPS (Diluted) | -0.17 | -0.03 | -0.37 | -1.31 | -3.83 | -4.49 | Upgrade
|
| Free Cash Flow | -2.94 | 3.19 | -9.7 | -17.21 | -34.06 | -30.69 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | 0.10 | -0.42 | -1.20 | -3.99 | -4.46 | Upgrade
|
| Gross Margin | 15.15% | 17.23% | 10.41% | 5.60% | -3.91% | 4.38% | Upgrade
|
| Operating Margin | -6.37% | 0.60% | -7.98% | -23.05% | -48.98% | -45.69% | Upgrade
|
| Profit Margin | -7.85% | -0.77% | -10.27% | -25.65% | -52.76% | -49.66% | Upgrade
|
| Free Cash Flow Margin | -3.89% | 3.14% | -11.60% | -23.64% | -54.99% | -49.34% | Upgrade
|
| EBITDA | -2.62 | 2.79 | -5.23 | -16.2 | -29.67 | -27.59 | Upgrade
|
| EBITDA Margin | -3.47% | 2.75% | -6.25% | -22.25% | -47.91% | -44.35% | Upgrade
|
| D&A For EBITDA | 2.19 | 2.18 | 1.44 | 0.58 | 0.67 | 0.83 | Upgrade
|
| EBIT | -4.81 | 0.61 | -6.67 | -16.78 | -30.34 | -28.42 | Upgrade
|
| EBIT Margin | -6.37% | 0.60% | -7.98% | -23.05% | -48.98% | -45.69% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.